Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
U.S. Clinical Nutrition Market, By Type (Enteral Nutrition (Standard Nutrition and Disease Specific Nutrition) and Parenteral Nutrition (Amino Acids, Carbohydrates, Vitamins and Minerals and Others (Fibers, etc.)), By Form (Powder, Liquid and Others (Solid,etc.)), By Age Group (Infant Nutrition, Adult Nutrition and Geriatric Nutrition), By Application (Diabetes, Gastrointestinal Diseases, Cancer, Neurological Disorder, Metabolic Syndrome and Other (Critical Care, etc.)), By End User (Hospitals, Home Care Setting, Long Term Care Facilities, Ambulatory Surgical Centers and Others (Research Institutes, etc.))
... Age Group (Infant Nutrition, Adult Nutrition and Geriatric Nutrition), By Application (Diabetes, Gastrointestinal Diseases, Cancer, Neurological Disorder, Metabolic Syndrome and Other (Critical Care, etc.)), By End User (Hospitals, Home Care Setting, Long Term Care Facilities, ... Read More
-
United States Nutraceuticals Market Assessment, By Product Type [Dietary Supplements, Functional Foods, Functional Beverages], By Ingredient [Vitamins, Minerals, Fibers & Speciality Carbohydrates, Fatty Acid, Botanicals, Prebiotics & Probiotics, Proteins & Amino Acids, Others], By Dosage Forms [Capsules, Tablets, Gummies, Liquid Water Enhancer, Liquids, Powders, Others], By Flavours [Chocolate, Orange, Strawberry, Vanilla, Unflavoured, Others], By Application [Energy & Weight Management, Bone & Joint Health, General Health, Immunity, Gastrointestinal Health, Lungs Detox/Cleanse, Sexual Health, Skincare, Anti-Aging, Insomnia], By End-user [Men, Women, Kids], By Packaging [Plastics, Biopolymers, Paperboards, Others], By Distribution Channel [Hypermarkets/Supermarkets, Pharmacies, Speciality Stores, Practitioner, E-Retailers, Others], By Region, Opportunities and Forecast, 2016-2030F
... Forms [Capsules, Tablets, Gummies, Liquid Water Enhancer, Liquids, Powders, Others], By Flavours [Chocolate, Orange, Strawberry, Vanilla, Unflavoured, Others], By Application [Energy & Weight Management, Bone & Joint Health, General Health, Immunity, Gastrointestinal Health, Lungs Detox/Cleanse, ... Read More
-
Neonatal and Preterm Infants Enteral Feeding Devices Market, by Product Type (Enteral Feeding Pumps, Low Profile Gastrostomy, PEG Tube, Nasogastric Tube, Gastrostomy Tube, and Giving Set), by End User (Home Care Settings, Hospitals, and Others (Ambulatory Centers, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
... (Ambulatory Centers, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Neonatal and Preterm Infants Enteral Feeding Devices Market, by Product Type (Enteral Feeding Pumps, Low Profile Gastrostomy, PEG ... Read More
-
Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2023 Including: 1) By Drug Type: Lubiprostone; Linaclotide; Eluxadoline; Rifaximin; Alosetron 2) By Indication: IBS With Constipation; IBS With Diarrhea; IBS With Alternating Constipation And Diarrhea 3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies 4) By End-Users: Hospitals; Clinics; Homecare Settings Covering: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Novartis AG; AstraZeneca plc
... Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies4) By End-Users: Hospitals; Clinics; Homecare SettingsCovering: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Novartis AG; AstraZeneca plc Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2023 ... Read More
-
Barrett's Esophagus Global Market Report 2023 Including: 1) By Type: No Dysplasia; Low-Grade Dysplasia; High Grade Dysplasia 2) By Treatment: Medication; Endoscopic Therapy; Surgery 3) By Route Of Administration: Oral; Parenteral; Rectal 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: F Hoffmann-La Roche Ltd.; Sanofi SA; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited
... Retail Pharmacy; Online PharmacyCovering: F Hoffmann-La Roche Ltd.; Sanofi SA; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited Barrett's Esophagus Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
South & Central America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above ... Read More
-
Europe Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 ... Read More
-
Asia Pacific Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, ... Read More
-
Middle East & Africa Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above ... Read More
-
North America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, ... Read More
-
Global Stomach Cancer Treatment Market - 2023-2030
... the forecast period 2023-2030. Stomach cancer is a disease in which malignant (cancer) cells are formed in the stomach lining. Stomach cancer usually begins in the mucus-producing cells that line the stomach. Symptoms of stomach ... Read More
-
Global Digestive Tract Capsule Endoscopy Market Growth 2023-2029
... downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Digestive Tract Capsule Endoscopy is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review ... Read More
-
Ulcerative Colitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028. Ulcerative colitis (UC) refers to a chronic inflammatory bowel disease (IBD) that causes irritation, inflammation, and ulcers (sores) in the ... Read More
-
Clinical Nutrition Market: By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Others); By End User (Pediatric, Adults and Geriatric), And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
... Forecasts To 2031 Clinical Nutrition Market: By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Others); By End User (Pediatric, Adults and Geriatric), And Region – Global Analysis of Market Size, Share & Trends ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical trials scenario. This report provides top line data relating to ... Read More
-
2023 Diseases of the Digestive System Global Market Size & Growth Report with Global Recession Risk Impact
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. The ... Read More
-
NASH Treatment & Therapeutics Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Prevalence of Non-alcoholic Steatohepatitis (NASH) ... Read More
-
Gastrointestinal Stent Market Analysis and Forecast to 2032: By Product (Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents, Esophageal Stents), Material (Self-Expanding Metal Stents, Plastic Stents), Application (Biliary Diseases, Irritable Bowel Syndrome, Gastrointestinal Cancers), End User (Hospitals & Clinics, Ambulatory Surgical Centers), and Region
... User (Hospitals & Clinics, Ambulatory Surgical Centers), and Region The global Gastrointestinal Stent market size was USD 467 million in 2022 and is anticipated to reach USD 796.8 million in 2032, growing at a rate ... Read More
-
Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028
... cells market is projected to reach USD 2.8 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 10.5% during the forecast period. On the basis of origin, the primary cells market ... Read More
-
Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2027
... Analysis and Industry Forecast, 2027 The Natural Killer (NK) Cells Therapeutics market refers to the pharmaceutical products and therapies aimed at utilizing and enhancing the functions of natural killer cells for therapeutic purposes. Natural killer ... Read More
-
Immunodiagnostics Market Forecast to 2030 - Global Analysis by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others), and Geography
... Diagnostic Laboratories, Academic & Research Institutes, and Others), and Geography The immunodiagnostics market size is expected to reach US$ 34,487.80 million by 2030 from US$ 19,218.89 million in 2022; it is estimated to record a ... Read More
-
2023 Global Forecast for Pressure Ulcers Treatment Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2023 Global Forecast for Oral Rehydration Salt Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Ulcerative Colitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Ulcerative Colitis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Digital Therapeutics Market by Application (Mental health, Diabetes, Respiratory, Neurology, Gastrointestinal, Cardiovascular, Addiction, Rehabilitation, Oncology, Sleep Disorder), Type (Disease Prevention, Management), End User—Global Forecast to 2030
... $42.98 billion by 2030 at a CAGR of 31.1% from 2023 to 2030. Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, ... Read More
Research Assistance
